Seattle biotech startup Rhizome Research has emerged from stealth with technology for creating small-molecule drug candidates ...

In the realm of modern medicine, RNA-based therapies have emerged as a promising avenue, with significant advancements in metabolic diseases, oncology, and preventive vaccines. A recent article ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Experts have been raising concerns about “AI washing.” One of these experts, futurist Bernard Marr, has said that AI washing “involves exaggerating the capabilities of a product or service that is ...

The artificial intelligence-powered drug designer Atomwise has raised $123 million in venture capital funding, to both scale up its platform and its partnerships with large biopharma companies, and to ...

After reportedly flirting with going public for years, the artificial intelligence-powered drug developer Insilico Medicine has laid out plans to raise about $292 million through a listing on the ...

SCIENTIFIC PAPERS are normally models of discreet understatement. They are also (or are at least supposed to be) loaded with the information needed for others to replicate their findings. Not this one ...

Isomorphic Labs, the AI-powered drug company spun out of Google’s DeepMind, just announced that it’s “getting ready” to begin human clinical trials of drugs designed by AI. The news comes as tech ...

When it comes to developing a new medicine, designing the active compound is only half the battle. “Many potential therapeutic compounds are hydrophobic—oily—so they’re not very stable in aqueous ...

Conversations on drug forums can get nerdy. People looking to push the barriers of their mental and bodily experience tend to know a lot about the vagaries of the law, organic chemistry, metaphysics ...